» Articles » PMID: 33804918

Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 3
PMID 33804918
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages act as immune scavengers and are important cell types in the homeostasis of various tissues. Given the multiple roles of macrophages, these cells can also be found as tissue resident macrophages tightly integrated into a variety of tissues in which they fulfill crucial and organ-specific functions. The lung harbors at least two macrophage populations: interstitial and alveolar macrophages, which occupy different niches and functions. In this review, we provide the latest insights into the multiple roles of alveolar macrophages while unraveling the distinct factors which can influence the ontogeny and function of these cells. Furthermore, we will highlight pulmonary diseases, which are associated with dysfunctional macrophages, concentrating on congenital diseases as well as pulmonary infections and impairment of immunological pathways. Moreover, we will provide an overview about different treatment approaches targeting macrophage dysfunction. Improved knowledge of the role of macrophages in the onset of pulmonary diseases may provide the basis for new pharmacological and/or cell-based immunotherapies and will extend our understanding to other macrophage-related disorders.

Citing Articles

Macrophage pyroptosis and its crucial role in ALI/ARDS.

Cai Y, Shang L, Zhou F, Zhang M, Li J, Wang S Front Immunol. 2025; 16:1530849.

PMID: 40028334 PMC: 11867949. DOI: 10.3389/fimmu.2025.1530849.


New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.

Kontoghiorghes G Antioxidants (Basel). 2025; 14(1).

PMID: 39857363 PMC: 11763074. DOI: 10.3390/antiox14010029.


Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.

Fernandez-Garcia R, Fraguas-Sanchez A Pharmaceutics. 2025; 16(12.

PMID: 39771562 PMC: 11677881. DOI: 10.3390/pharmaceutics16121584.


Human CFTR deficient iPSC-macrophages reveal impaired functional and transcriptomic response upon infection.

Rodriguez Gonzalez C, Basilio-Queiros D, Neehus A, Merkert S, Tschritter D, Unal S Front Immunol. 2024; 15:1397886.

PMID: 39606224 PMC: 11601075. DOI: 10.3389/fimmu.2024.1397886.


Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury.

Ahmad S, Nasser W, Ahmad A Front Immunol. 2024; 15:1488913.

PMID: 39582870 PMC: 11581858. DOI: 10.3389/fimmu.2024.1488913.


References
1.
Fitzpatrick A, Holguin F, Teague W, Brown L . Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol. 2008; 121(6):1372-8, 1378.e1-3. PMC: 2442216. DOI: 10.1016/j.jaci.2008.03.008. View

2.
Divithotawela C, Apte S, Tan M, De Silva T, Chambers D . Pulmonary alveolar proteinosis after lung transplantation. Respirol Case Rep. 2020; 8(5):e00566. PMC: 7199162. DOI: 10.1002/rcr2.566. View

3.
Costabel U, Nakata K . Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune?. Am J Respir Crit Care Med. 2010; 181(5):427-8. DOI: 10.1164/rccm.200912-1800ED. View

4.
Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T . Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity. 1995; 2(3):211-22. DOI: 10.1016/1074-7613(95)90046-2. View

5.
Watanabe K, Sueishi K, Tanaka K, Nagata N, Hirose N, Shigematsu N . Pulmonary alveolar proteinosis and disseminated atypical mycobacteriosis in a patient with busulfan lung. Acta Pathol Jpn. 1990; 40(1):63-6. DOI: 10.1111/j.1440-1827.1990.tb01530.x. View